The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
作者信息
Zach M S
机构信息
Paediatric Department, University of Graz, Austria.
出版信息
Thorax. 1996 Jul;51(7):750-5. doi: 10.1136/thx.51.7.750.
Abstract
摘要
相似文献
1
The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
Thorax. 1996 Jul;51(7):750-5. doi: 10.1136/thx.51.7.750.
2
Recombinant human DNase in cystic fibrosis.
Lancet. 1999 Jul 31;354(9176):428. doi: 10.1016/S0140-6736(05)75848-7.
3
[Cystic fibrosis: current therapy. Inhalation therapy with recombinant DNAse].
Schweiz Med Wochenschr Suppl. 2000;122:47S-48S.
4
Which DNAse in cystic fibrosis?
Lancet. 1993 Sep 4;342(8871):624-5. doi: 10.1016/0140-6736(93)91457-w.
5
DNase in cystic fibrosis: the challenge of assessing response and maximising benefit.
Thorax. 1998 Dec;53(12):1003-4. doi: 10.1136/thx.53.12.1003.
6
Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.
JAMA. 1992 Apr 8;267(14):1947-51.
7
Neutrophil proteinases and rhDNase therapy in cystic fibrosis.
Eur Respir J. 1996 Nov;9(11):2193-5. doi: 10.1183/09031936.96.09112193.
8
DNase trials in cystic fibrosis.
Eur Respir J. 1995 Oct;8(10):1786-91. doi: 10.1183/09031936.95.08101786.
9
Placebo-controlled n-of-1 trials in cystic fibrosis.
Eur Respir J. 1999 Oct;14(4):993; author reply 994. doi: 10.1034/j.1399-3003.1999.14d45.x.
10
Placebo-controlled n-of-1 trials in cystic fibrosis.
Eur Respir J. 1999 Oct;14(4):993; author reply 994. doi: 10.1034/j.1399-3003.1999.14d44.x.
引用本文的文献
1
Multifunctional Boron-based 2D Nanoplatforms Ameliorate Severe Respiratory Inflammation by Targeting Multiple Inflammatory Mediators.
Adv Sci (Weinh). 2025 Apr;12(13):e2412626. doi: 10.1002/advs.202412626. Epub 2025 Feb 14.
2
Polyglycerol-Amine Covered Nanosheets Target Cell-Free DNA to Attenuate Acute Kidney Injury.
Adv Sci (Weinh). 2023 Aug;10(23):e2300604. doi: 10.1002/advs.202300604. Epub 2023 Jun 5.
3
The road for survival improvement of cystic fibrosis patients in Arab countries.
Int J Pediatr Adolesc Med. 2015 Jun;2(2):47-58. doi: 10.1016/j.ijpam.2015.05.006. Epub 2015 Jun 19.
4
Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa.
Infect Immun. 2016 Jul 21;84(8):2355-2361. doi: 10.1128/IAI.00233-16. Print 2016 Aug.
5
Long-term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis.
Thorax. 1998 Dec;53(12):1014-7. doi: 10.1136/thx.53.12.1014.
本文引用的文献
1
Liquefaction of viscous purulent exudates by deoxyribonuclease.
Lancet. 1950 Dec 9;2(6641):739-42. doi: 10.1016/s0140-6736(50)91676-x.
2
STUDIES ON PULMONARY SECRETIONS. I. THE OVER-ALL CHEMICAL COMPOSITION OF PULMONARY SECRETIONS FROM PATIENTS WITH CYSTIC FIBROSIS, BRONCHIECTASIS, AND LARYNGECTOMY.
Am Rev Respir Dis. 1963 Aug;88:199-204. doi: 10.1164/arrd.1963.88.2.199.
3
Aerosolized pancreatic dornase and antibiotics in pulmonary infections: use in patients with postoperative and nonoperative infections.
JAMA. 1961 Dec 2;178:878-86. doi: 10.1001/jama.1961.03040480008003.
4
Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis.
Pediatrics. 1959 Nov;24:739-45.
5
In-vitro evaluation of effect of enzymes on tracheobronchial secretions from patients withcystic fibrosis.
Pediatrics. 1961 Apr;27:589-96.
6
Aerosols of pancreatic dornase in bronchopulmonary disease.
Ann Allergy. 1954 Jan-Feb;12(1):71-7.
7
Deoxyribonuclease in the treatment of purulent bronchitis.
Thorax. 1953 Dec;8(4):295-300. doi: 10.1136/thx.8.4.295.
8
DNase trials in cystic fibrosis.
Eur Respir J. 1995 Oct;8(10):1786-91. doi: 10.1183/09031936.95.08101786.
9
Effects of combined treatment with rhDNase and airflow oscillations on spinnability of cystic fibrosis sputum in vitro.
Pediatr Pulmonol. 1995 Aug;20(2):78-82. doi: 10.1002/ppul.1950200205.
10
The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis.
Pediatr Pulmonol. 1995 Aug;20(2):63-70. doi: 10.1002/ppul.1950200203.
Zotero 插件